Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Phexxi (citric acid/lactic acid/potassium bitartrate) / Evofem Biosci
EVOGUARD, NCT04553068: Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection	Completed	3	1892	US	EVO100, Placebo	Evofem Inc.	Sexually Transmitted Diseases, Gonorrhea, Chlamydia	07/22	07/22
NCT05753813: Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome	Recruiting	1	22	US	Phexxi	Queen's Medical Center, University of Hawaii Foundation	Bacterial Vaginosis, Vulvovaginal Candidiasis	10/25	12/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Phexxi (citric acid/lactic acid/potassium bitartrate) / Evofem Biosci
EVOGUARD, NCT04553068: Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection	Completed	3	1892	US	EVO100, Placebo	Evofem Inc.	Sexually Transmitted Diseases, Gonorrhea, Chlamydia	07/22	07/22
NCT05753813: Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome	Recruiting	1	22	US	Phexxi	Queen's Medical Center, University of Hawaii Foundation	Bacterial Vaginosis, Vulvovaginal Candidiasis	10/25	12/25